3:14 PM
 | 
Jul 10, 2017
 |  BC Extra  |  Company News

Broad throws down gauntlet for CRISPR pool

The Broad Institute of MIT and Harvard is the first major player in the international CRISPR IP dispute to disclose its participation in a CRISPR-Cas9 joint licensing pool, but the pool won't have its intended impact unless other players follow suit.

On June 28, the Broad Institute responded to a call from IP rights management company MPEG LA LLC for CRISPR-Cas9 patent holders to participate in the creation of a global CRISPR-Cas9 Joint Licensing Platform that would make it easier for potential licensees to access all the IP required to commercialize CRISPR-based tools, technologies and therapeutics. In its response, the Broad Institute submitted ten patent families comprising at least 22 issued patents and pending...

Read the full 558 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >